These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7823750)

  • 41. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Valencia ME; Moreno V; Laguna F; González-Lahoz JM
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapy for Tuberculous Meningitis.
    van Crevel R; Ruslami R; Aarnoutse R
    N Engl J Med; 2016 Jun; 374(22):2187. PubMed ID: 27248635
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapy for Tuberculous Meningitis.
    Heemskerk AD; Bang ND; Thwaites GE
    N Engl J Med; 2016 Jun; 374(22):2188-9. PubMed ID: 27248634
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapy for Tuberculous Meningitis.
    Sudhindra P; Nowakowski J
    N Engl J Med; 2016 Jun; 374(22):2188. PubMed ID: 27248637
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy for Tuberculous Meningitis.
    Boeree MJ; Gillespie SH; Hoelscher M;
    N Engl J Med; 2016 Jun; 374(22):2187-8. PubMed ID: 27248636
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 47. RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Hemanth Kumar AK; Narendran G; Kumar RS; Ramachandran G; Sekar L; Raja K; Swaminathan S
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):805-7. PubMed ID: 26056105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HIV infection and tuberculosis].
    Brodt HR
    Internist (Berl); 1995 Oct; 36(10):970-9. PubMed ID: 7499073
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL; Brink BA
    S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y; Shigeno Y; Shigeno H; Nakazato H; Nagasawa M; Koga H; Tomita H; Tomonaga A; Yamaguchi K; Izumikawa K
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract]   [Full Text] [Related]  

  • 53. Failure of a prothionamide-containing oral antituberculosis regimen.
    Langton ME; Cowie RL
    S Afr Med J; 1985 Dec; 68(12):881. PubMed ID: 4071346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Short-term intensive therapy of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Kunichan AD
    Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
    Singh R; Marshall N; Smith CJ; Reynolds CJ; Breen RA; Bhagani S; Cropley I; Hopkins S; Swaden L; Johnson MA; Lipman MC
    AIDS; 2013 Jan; 27(3):481-4. PubMed ID: 23014518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rifampicin in the treatment of tuberculosis in children].
    Sibila S; Fierbinţeanu O
    Ftiziologia; 1972; 21(6):597-602. PubMed ID: 4539463
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapy and prognosis of tuberculosis].
    Fischer B; Ferlinz R
    Versicherungsmedizin; 1995 Dec; 47(6):212-6. PubMed ID: 8571498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy for Tuberculous Meningitis.
    Donald PR
    N Engl J Med; 2016 Jan; 374(2):179-81. PubMed ID: 26760090
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.